Aciont, Inc.
🇺🇸United States
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Safety and Efficacy Study of DSP-Visulex for the Treatment of Anterior Uveitis
Phase 1
Completed
- Conditions
- Non-Infectious Anterior Uveitis
- Interventions
- First Posted Date
- 2014-12-05
- Last Posted Date
- 2017-04-27
- Lead Sponsor
- Aciont Inc
- Target Recruit Count
- 44
- Registration Number
- NCT02309385
- Locations
- 🇺🇸
Massachusetts Eye Research and Surgery Institution (MERSI), Cambridge, Massachusetts, United States
🇺🇸Charlotte Eye, Ear, Nose, and Throat Associates, Charlotte, North Carolina, United States
🇺🇸Bergstrom Eye Research, Fargo, North Dakota, United States
News
No news found